C
C Kells
Researcher at Halifax
Publications - 7
Citations - 738
C Kells is an academic researcher from Halifax. The author has contributed to research in topics: Myocardial infarction & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 733 citations.
Papers
More filters
Journal ArticleDOI
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
Peter Stone,Bruce Thompson,H. V. Anderson,M W Kronenberg,Robert S. Gibson,William J. Rogers,Daniel J. Diver,Pierre Theroux,J W Warnica,J B Nasmith,C Kells,Neal S. Kleiman,Carolyn H. McCabe,Mark Schactman,Genell L. Knatterud,Eugene Braunwald +15 more
TL;DR: Among patients presenting with acute ischemic chest pain without persistent ST-segment elevation, blacks appeared to have less severe coronary disease, received revascularization less frequently, and had less recurrent ischemia compared with nonblacks, which suggests that more aggressive strategies should be directed to those patients with the greatest likelihood of adverse outcomes.
Journal ArticleDOI
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study
Christopher P. Cannon,Carolyn H. McCabe,Peter Stone,William J. Rogers,Mark Schactman,Bruce Thompson,D. J. Pearce,Daniel J. Diver,C Kells,Ted Feldman,Michelle A. Williams,Robert S. Gibson,M W Kronenberg,Leonard I. Ganz,H. V. Anderson,Eugene Braunwald +15 more
TL;DR: The admission ECG is very useful in risk stratifying patients with non-Q wave MI, whereas T wave inversion does not add to the clinical history in predicting outcome.
Journal ArticleDOI
Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial.
J. Bengtson,M. Adolphson,D. L. Brewer,David R. Jacobs,J. L. Gard,L. Cahoon,M. Bloom,B. Kennelly,K. Porter,J. Kmonicek,F. M. Krainin,J. Shane,Jean-Francois Marquis,Sharon Ann Kearns,David J. Moliterno,P. DeSantis,Erik Magnus Ohman,C. Martz,David L. Brown,M. Bulley,Seth J. Worley,J. Slovak,L. Hollywood,K. Knepper,K. Browne,M. Telatnik,Martin J. Frey,T. Browning,William J. French,Shaojun Wang,Neal S. Kleiman,L. Baysinger,A. Edwards,Gérald Barbeau,M. M. Lariviere,James B. Hermiller,S. Diel,J. S. Wilson,A. Friedewald,A. N. Tenaglia,R. Bozeman,W. Roper,W. Grossman,K. Fletcher,R. Andersen,Douglas Spriggs,S. Wahl,J. D. Talley,M. Boyles,D. Almond,Joanne White,A. G. Adelman,V. Foulger,S. Webber,C Kells,T. Fawcett,J. Butler,J. Scrivner,M. J. Miller,B. Owens,C. Corder,C. Clinton,Jeffery J. Johnson,M. Myrna,K. Carr,J. Calarco,J. Glassman,A. Stein,D. Marsh,B. Penny,D. Small,D. Goodman,D. Walston,M. J. Koren,K. Teeter,M. Hudson +75 more
TL;DR: Efegatran sulfate appeared to offer no clear advantage over heparin as an adjunct to thrombolysis for acute myocardial infarction, although there may be a modest improvement in time to reperfusion.
Journal ArticleDOI
Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
Kyle Murnaghan,Helen Bishop,Navjot Sandila,Bakhtiar J. Kidwai,Lawrence M. Title,Ata ur Rehman Quraishi,C Kells,Hussein Beydoun,Osama Elkhateeb +8 more
TL;DR: The data indicate that at one year, DEBs provide an effective alternative to stenting for in-stent restenosis, and the five-year data demonstrate high rates of MACE, indicating that DEB provides both short-term and long-term benefits in ISR.
Journal ArticleDOI
Adult congenital heart disease health services in canada-where have we come in the past 15 years
Robin Jacob Mao,Luc M. Beauchesne,Ariane Marelli,Candice K. Silversides,Annie Dore,Jean Ganame,Michelle Keir,R. Alonso-Gonzalez,Isabelle Vonder Muhll,Jasmine Grewal,A. Williams,Payam Dehghani,Sharmayne Siu,Amit Johri,E. R. Bedard,Judith Therrien,C Kells,D. Hayami,Robin A. Ducas +18 more
TL;DR: In this article , a survey detailing infrastructure and human resources was sent to all CACH ACHD centers across Canada to evaluate the evolution in provision of care over the past 15 years.